https://www.thebodypro.com/author/myles-helfand
Myles Helfand Img

Myles Helfand

Executive Editor

Myles is the executive editor and general manager of TheBody/TheBodyPro. A career journalist and editor, Myles joined TheBody in 2001 as a part-time copyeditor. He has since established himself as a leading journalist and content strategist on HIV-related issues, authoring hundreds of articles and editing hundreds more -- and accumulating an ever-growing mountain of HIV conference badges along the way.

Latest by Myles Helfand

empty shot
News

This Week in HIV Research: The Complexities of Alcohol and Substance Use

April 15, 2021: Alcohol and neurocognitive impairment; using hair analysis to measure substance use; integrase inhibitors' impact on verbal learning; hepatocellular carcinoma trends among PLWH.

By Barbara Jungwirth and Myles Helfand
David Alain Wohl recaps CROI 2021 research during a video interview
Conference Coverage

CROI 2021 Highlights: New HIV Research With Clinical Impact

Here's a walkthrough of some of the most compelling stories coming out of the year's biggest HIV science meeting to date.

By Myles Helfand
American teens
News

This Week in HIV Research: We Need to Better Serve Our Teens

April 8, 2021: PrEP “contemplation” and uptake among adolescents; adolescent perception of HIV risk; HIV diagnosis rates among transgender people; PrEP and HIV incidence in Scotland.

By Barbara Jungwirth and Myles Helfand
Hippocratic oath
News

This Week in HIV Research: U=U and the Hippocratic Oath

April 1, 2021: The ethics of teaching U=U; the role of primary care in HIV service acceptance; STI testing rates in transgender women; the potential in anal self-sampling.

By Barbara Jungwirth and Myles Helfand
COVID-19 mask ground
News

This Week in HIV Research: The Indirect Harms of the COVID-19 Pandemic

March 25, 2021: HIV disease progression spikes in a London hospital; neurocognitive impairment and frailty in PLWH; the smell of HIV-associated neurocognitive disorder; statin usage and physical function decline.

By Barbara Jungwirth and Myles Helfand
umbrella
News

This Week in HIV Research: Under One Roof

March 18, 2021: Improving viral suppression among PLWH experiencing homelessness; co-located PrEP services for trans women; subsidized health care and PrEP uptake; Heplisav-B hepatitis B vaccine efficacy in PLWH.

By Barbara Jungwirth and Myles Helfand
CROI 2021 virtual oral abstract session featuring speakers in tiny video boxes
Conference Coverage

CROI 2021 Data Bites: HIV Treatment and the Care Continuum

Our bite-sized study summaries include new research on antiretrovirals in development, trends in antiretroviral initiation speed and viral suppression rates in the U.S., and the link between gender-affirming surgery and an undetectable viral load.

By Myles Helfand and Larry Buhl
Screenshot from CROI 2021 oral abstract session on complications of HIV and COVID-19
Conference Coverage

CROI 2021 Data Bites: HIV and COVID-19

There's new research on the risk of severe COVID-19 among people living with HIV, as well as prevention and treatment options.

By Larry Buhl and Myles Helfand
video conference
News

This Week in HIV Research: While You Were CROI-ing

March 11, 2021: Anticholinergic medications and neurocognitive issues; weight gain and dolutegravir in older men; drug interaction risks on B/F/TAF; real-world efficacy of HBV-active HIV treatment.

By Barbara Jungwirth and Myles Helfand
Researchers on a Zoom meeting during a CROI 2021 press conference
Conference Coverage

CROI 2021 Data Bites: HIV Prevention and Epidemiology

From new forms of PrEP to new data on HIV in the U.S., CROI 2021 has plenty of developments to report when it comes to preventing HIV and better understanding the drivers of the modern epidemic.

By Myles Helfand and Larry Buhl